Home / Inspections / 1232473

FDA Inspection 1232473 — Recipharm Pharmaservices Private Limited

Recipharm Pharmaservices Private Limited — FEI 3009150119

The FDA completed an inspection of Recipharm Pharmaservices Private Limited on March 22, 2024 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 22, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Facility

Other inspections at this facility

  • 1119410 (VAI Thu Feb 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1079034 (VAI Fri Feb 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1053644 (NAI Fri May 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 921695 (NAI Thu Mar 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 805946 (VAI Thu Nov 01 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources